COUNTER-DRUG TECHNOLOGY ASSESSMENT CENTER

SEC. 1011. COUNTER-DRUG TECHNOLOGY ASSESSMENT CENTER Title I of the Anti-Drug Abuse Act of 1988 (21 U.S.C. 1501 et seq.) is amended by inserting after section 1003 the following new section: “SEC. 1003A. COUNTER-DRUG TECHNOLOGY ASSESSMENT CENTER “(a) Establishment.— There is established within the Office of National Drug Control Policy, the Counter-Drug Technology Assessment Center (hereinafter in this section referred to as the ‘Center’). The Center shall operate under the authority of the Director of National Drug Control Policy and shall serve as the central counter-drug enforcement research and development organization of the United States Government. “(b) Director.— There shall be at the head of the Center the Chief Scientist of Counter-Drug Technology (hereinafter in this section referred to as the ‘Chief Scientist’). The Chief Scientist shall be appointed by the Director of National Drug Control Policy from among individuals qualified and distinguished in the area of science, engineering, or technology. “(c) Additional Responsibilities of the Director.— (1) The Director, acting through the Chief Scientist, shall— 104 STAT. 1634 “(A) identify and define the short, medium, and long-term scientific and technological needs of Federal, State, and local drug enforcement agencies, including— “(i) advanced surveillance, tracking, and radar imaging; “(ii) electronic support measures; “(iii) communications; “(iv) data fusion, advanced computer systems and artificial intelligence; and “(v) chemical, biological, radiological (including neutron, electron, and graviton) and other means of detection; “(B) make a priority ranking of such needs according to fiscal and technological feasibility, as part of a National Counter-Drug Enforcement Research and Development Strategy; “(C) oversee and coordinate counter-drug technology initiatives with related activities of other Federal civilian and military departments; and “(D) under the general authority of the Director of National Drug Control Policy, submit requests to Congress for the reprogramming or transfer of funds appropriated for counter-drug enforcement research and development. “(2) The authority granted to the Director under this section shall not extend to the award of contracts, management of individual projects, or other operational activities. “(d) Counter-Drug Budget Submission.— Beginning with the budget submitted to Congress for fiscal year 1992 pursuant to section 1105 of title 31, United States Code, the President shall submit a separate and detailed request relating to those Federal departments and agencies having responsibility for counter-drug enforcement research and development programs. “(e) Personnel.— Subject to subsections (d) and (e) of section 1003, the Chief Scientist shall select and appoint a staff of not more than 10 employees with specialized experience in scientific, engineering, and technical affairs.”.